Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers - Additional Information (Details)

v3.20.2
Revenues from Contracts and Significant Customers - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue from Contract with Customer, Including Assessed Tax $ 9,447 $ 9,492 $ 30,808 $ 23,816
Revenue [Member]        
Concentration Risk, Customer none of the Company’s Dermatology Products customers accounted for more than 10% of its total gross product revenue   one of the Company’s Dermatology Products customers accounted for more than 10% of its total gross product revenue  
Accounts Receivable [Member]        
Concentration Risk, Customer     one of the Company’s Dermatology Products customers accounted for more than 10% of its total accounts receivable balance at 14.5% two of the Company’s Dermatology Products customers accounted for more than 10% of its total accounts balance in the amounts of $3.5 million and $2.8 million
Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Concentration risk, percentage     14.50%  
Customer One [Member] | Accounts Receivable [Member]        
Accounts Receivable, Net   3,500   $ 3,500
Customer Two [Member] | Accounts Receivable [Member]        
Accounts Receivable, Net   $ 2,800   $ 2,800
3PL Title Model [Member] | Revenue [Member] | Customer Concentration Risk [Member]        
Concentration risk, percentage   60.00%   76.00%